Intrarenal Resistive Index after Renal Transplantation

Maarten Naesens, Line Heylen, Evelyne Lerut, +15

New England Journal of Medicine

CYP3A5 and CYP3A4 but not MDR1 Single-nucleotide Polymorphisms Determine Long-term Tacrolimus Disposition and Drug-related Nephrotoxicity in Renal Recipients

Dirk Kuypers, Hylke de Jonge, Maarten Naesens, +3

Clinical Pharmacology & Therapeutics

Recovery of Hyperphosphatoninism and Renal Phosphorus Wasting One Year after Successful Renal Transplantation

Pieter Evenepoel, Björn Meijers, Hylke de Jonge, +5

Clinical Journal of the American Society of Nephrology

Donor Age and Renal P-Glycoprotein Expression Associate with Chronic Histological Damage in Renal Allografts

Maarten Naesens, Evelyne Lerut, Hylke de Jonge, +3

Journal of the American Society of Nephrology

Donor Kidney QualityRenal PathologyImmunologyPathologyTacrolimus Exposure +17

The P450 Oxidoreductase<i>*28</i>SNP is Associated with Low Initial Tacrolimus Exposure and Increased Dose Requirements in CYP3A5-Expressing Renal Recipients

Hylke de Jonge, Christoph Metalidis, Maarten Naesens, +2

Pharmacogenomics

In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients

Hylke de Jonge, Henriëtte de Loor, Kristin Verbeke, +2

Clinical Pharmacology & Therapeutics

Tacrolimus Dose Requirements and CYP3A5 Genotype and the Development of Calcineurin Inhibitor-Associated Nephrotoxicity in Renal Allograft Recipients

Dirk Kuypers, Maarten Naesens, Hylke de Jonge, +3

Therapeutic Drug Monitoring

Current target ranges of mycophenolic acid exposure and drug-related adverse events: A 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients

Dirk Kuypers, Hylke de Jonge, Maarten Naesens, +4

Clinical Therapeutics

UrologyTransplantationCurrent Target RangesKidney TransplantDrug-related Adverse Events +5

Calcium Metabolism in the Early Posttransplantation Period

Pieter Evenepoel, B. Van den Bergh, Maarten Naesens, +5

Clinical Journal of the American Society of Nephrology

Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients

Dirk Kuypers, Hylke de Jonge, Maarten Naesens, +1

Pharmacogenetics and Genomics